Perigon Wealth Management, LLC

Position in VTRS — Viatris Inc

CIK 1575239 SAN FRANCISCO, CA

Position in VTRS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$254,127

+$24,593 QoQ

Shares Held

16,003

-5.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#515

of 1,016 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 3% Shared 0% None 97%

Healthcare · as of Jun 30, 2026

Perigon Wealth Management, LLC holds $2,424,384 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HROW	Harrow, Inc.	13,229	$561,835
2	HIMS	Hims & Hers Health, Inc.	15,717	$544,908
3	LNTH	Lantheus Holdings, Inc.	3,524	$390,952
4	UTHR	UNITED THERAPEUTICS Corp	594	$321,847
5	VTRS	Viatris Inc This page	16,003	$254,127
6	RDY	Dr Reddys Laboratories Ltd	16,628	$240,939
7	HLN	Haleon plc	10,544	$98,375
8	ADCT	ADC Therapeutics SA	10,656	$11,401

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$254,127	16,003	-5.8%	Shares	Sole	2026-08-07
2026-03-31	$229,534	16,990	+2.1%	Shares	Sole	2026-04-10
2025-12-31	$207,180	16,641	-1.7%	Shares	Sole	2026-01-16
2025-09-30	$167,517	16,921	+37.5%	Shares	Sole	2025-10-17
2025-06-30	$109,892	12,306	-33.3%	Shares	Sole	2025-07-16
2025-03-31	$160,716	18,452	-5.6%	Shares	Sole	2025-04-23
2024-12-31	$243,385	19,549	+9.9%	Shares	Sole	2025-01-22
2024-09-30	$206,507	17,787	+15.2%	Shares	Sole	2024-10-16
2023-12-31	$167,215	15,440	+17.3%	Shares	Sole	2024-01-29
2023-09-30	$129,757	13,160	+3.6%	Shares	Sole	2023-10-30
2023-03-31	$122,212	12,704	-4.0%	Shares	Sole	2023-05-03
2022-12-31	$147,316	13,236	+437.2%	Shares	Sole	2023-05-01
2020-12-31	$46,175	2,464	—	Shares	Sole	2021-01-28
No filing history on record for this holder in this stock.